N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.
about
Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutonsAnti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesParaneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratomaCellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegenerationCathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neuronsCrystal Structure and Pharmacological Characterization of a Novel N-Methyl-D-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding SiteComputational investigation of the changing patterns of subtype specific NMDA receptor activation during physiological glutamatergic neurotransmissionThe KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.SK2 channels are neuroprotective for ischemia-induced neuronal cell deathMagnetic resonance and optical imaging probes for NMDA receptors on the cell surface of neurons: synthesis and evaluation in cellulo.Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activationEvolution of the aging brain transcriptome and synaptic regulationImplementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists.Subunit arrangement in N-methyl-D-aspartate (NMDA) receptorsAnti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Pathologically activated neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis(propyl)-cognitin.Mechanistic insights into xenon inhibition of NMDA receptors from MD simulationsGlutamate and its receptors in cancerLack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studiesSystem xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.Increasing small conductance Ca2+-activated potassium channel activity reverses ischemia-induced impairment of long-term potentiation.Structural mechanism of N-methyl-D-aspartate receptor type 1 partial agonismSubunit arrangement and function in NMDA receptors.Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.Anti-NMDA receptor antibodies in patients with a first episode of schizophreniaCoupling of the NMDA receptor to neuroprotective and neurodestructive events.Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report.Pregnanolone sulfate promotes desensitization of activated NMDA receptors.N-methyl D-aspartate receptor encephalitis: A new addition to the spectrum of autoimmune encephalitis.Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gatingLiposome reconstitution and modulation of recombinant N-methyl-D-aspartate receptor channels by membrane stretch.N-methyl-D-aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunit.Molecular pharmacology of human NMDA receptorsRegulation of NMDA receptors by phosphorylation.Bacopa monnieri Extract (CDRI-08) Modulates the NMDA Receptor Subunits and nNOS-Apoptosis Axis in Cerebellum of Hepatic Encephalopathy RatsMutations within the selectivity filter of the NMDA receptor-channel influence voltage dependent block by 5-hydroxytryptamine.NMDA receptor binding in focal epilepsiesInnovative approaches for the development of antidepressant drugs: current and future strategiesGating reaction mechanism of neuronal NMDA receptors.
P2860
Q24601769-AA891928-913D-4A1D-84D4-F1E836C542ECQ24642126-5AD249A2-34CE-42F4-9D18-2B01E51C7956Q24653500-56594F63-1EF6-4E78-BC5A-55B48D0394E0Q24654460-F0D1E3C3-7259-4AD1-9E68-48C5E9CE1EA4Q27305158-FE826578-71F0-4BD7-974B-4C641C9D08A2Q27680080-7BCC86B8-E266-49FC-8B64-B2A846F6D45EQ28478887-463C5B9E-8089-4D4D-8A57-ED651BF0A1D5Q30497430-8B534331-F688-442A-963A-828084A984B3Q30512907-B8185D2C-1F2D-4585-A2DD-1AB487AE9A7BQ30860400-F59E3C65-C036-4CF8-B230-287C3AC79A81Q31033150-082A8058-7DC7-431E-85DF-AB04395D16C6Q33373343-B46524D0-9AAE-48F4-AFBC-95158A88A0AEQ33536202-A3F52795-6678-422B-B2F7-4C9606CD5319Q33832632-E47FD2A3-87C9-4808-9D2C-94EC45F0608BQ33862239-AAFA9AD3-6183-4B07-8B07-403C92B0568EQ33924304-E2AC11EC-00ED-4149-A255-106EC67FAE81Q33990281-A0B79A56-7CC5-431D-852E-748D5FE98AB3Q34048497-11E95EE0-ECF2-4034-8E23-221ACC57F126Q34126315-C73FD3C1-8B97-4912-A488-866FDE447566Q34127075-5356CB51-AC7F-4AF6-8DC1-9708DF20FDB8Q34184493-7C05CD57-C0A3-4786-88D8-5FFFD7DD232EQ34381368-3D78CBC9-C0B4-4CA7-92D9-FCC86252D656Q34451002-26B2D60D-144E-4D1B-A42C-AA3C44D4FF8FQ34466595-94F920D5-27DF-419F-BBED-D48CD0906329Q34654483-A38149FA-35FD-41A5-9CA9-F52EC4B1EE6CQ34669114-A4E6F5AD-C2D5-463D-9972-E2A26749DECBQ35012580-3BED2F60-81F8-485A-9474-A2042ED2A317Q35063886-208199B4-5FF2-434B-B289-DC4FDEFD4079Q35148975-38C759C1-077F-475E-A8B9-7964E1BFCC33Q35430360-6E5F9C0D-0B9E-466B-891F-83ED1F384313Q35514668-DB8329DB-ED4B-4B3B-B971-7E06F3EC13A3Q35607015-5A5A9E8A-870B-4C6E-96F9-6DD23B5170CEQ35763200-BF4AC27B-C987-40D3-8FB6-B1DC971D139AQ35911379-B8264210-06F8-494A-8079-0B7BB5647CF6Q36026713-7AB20CB0-95F3-4E3C-89A2-DF207FC6A0A8Q36043633-82001100-B1CD-45E4-96B9-C0673E9FCC3DQ36052454-785A7531-0559-49AB-823C-F91C56A18BB5Q36150214-8654F2E1-5727-4EB3-93CA-55C547B96F16Q36401400-67D4AD90-82ED-441F-93D1-BE647708478AQ36531977-E11D5D9F-EB5F-4772-9930-D208B43BED60
P2860
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
N-methyl-D-aspartate receptor ...... city and neurological disease.
@ast
N-methyl-D-aspartate receptor ...... city and neurological disease.
@en
type
label
N-methyl-D-aspartate receptor ...... city and neurological disease.
@ast
N-methyl-D-aspartate receptor ...... city and neurological disease.
@en
prefLabel
N-methyl-D-aspartate receptor ...... city and neurological disease.
@ast
N-methyl-D-aspartate receptor ...... city and neurological disease.
@en
P356
P1433
P1476
N-methyl-D-aspartate receptor ...... city and neurological disease.
@en
P2093
David R Lynch
Elisa A Waxman
P356
10.1177/1073858404269012
P577
2005-02-01T00:00:00Z